Literature DB >> 6311891

The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone.

S Nicosia, D Oliva, G Giannattasio, A Spada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311891     DOI: 10.1007/BF03350614

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  47 in total

1.  Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.

Authors:  G Faglia; P Beck-Peccoz; C Ferrari; P Travaglini; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

2.  VIP stimulates prolactin release in women.

Authors:  B Ottesen; A N Andersen; T Gerstenberg; H Ulrichesen; T Manthorpe; J Fahrenkrug
Journal:  Lancet       Date:  1981-09-26       Impact factor: 79.321

3.  Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.

Authors:  J Epelbaum; L Tapia-Arancibia; J Besson; W H Rotsztejn; C Kordon
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

4.  Vasoactive intestinal polypeptide: release into hypophyseal portal blood.

Authors:  S I Said; J C Porter
Journal:  Life Sci       Date:  1979-01-15       Impact factor: 5.037

5.  Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.

Authors:  A Enjalbert; J Epelbaum; S Arancibia; L Tapia-Arancibia; M T Bluet-Pajot; C Kordon
Journal:  Endocrinology       Date:  1982-07       Impact factor: 4.736

6.  Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release.

Authors:  J Drouin; A De Léan; D Rainville; R Lachance; F Labrie
Journal:  Endocrinology       Date:  1976-02       Impact factor: 4.736

7.  Prolactin release by vasoactive intestinal polypeptide in rats.

Authors:  Y Kato; Y Iwasaki; J Iwasaki; H Abe; N Yanaihara; H Imura
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

8.  Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.

Authors:  A Shimatsu; Y Kato; N Matsushita; H Katakami; N Yanaihara; H Imura
Journal:  Endocrinology       Date:  1981-02       Impact factor: 4.736

9.  Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.

Authors:  P Onali; J P Schwartz; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP).

Authors:  C Borghi; S Nicosia; A Giachetti; S I Said
Journal:  FEBS Lett       Date:  1979-12-15       Impact factor: 4.124

View more
  2 in total

1.  Immunohistochemical localization of vasoactive intestinal peptide (VIP) in the circumventricular organs of the rat.

Authors:  J D Mikkelsen
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

2.  Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men.

Authors:  J Guldner; L Trachsel; C Kratschmayr; B Rothe; F Holsboer; A Steiger
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.